CHRISTY J JANSEN

Allopathic & Osteopathic Physicians|Pediatrics EMPORIA, KS NPI 1548466337

General Payments — all program years on this page

$239.77

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $170.50 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $170.5020

By paying entity

Latest program year (PY2019) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $120.3417
Regeneron Healthcare Solutions, Inc. $19.151
Genentech USA, Inc. $16.531
Amgen Inc. $14.481

By program year

Program yearAmountRecords
2018 $69.275
2019 $170.5020

Records — PY2019 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
662258265 Amgen Inc. $14.48 09/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
668759455 Novo Nordisk Inc $13.32 02/25/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
673399145 Regeneron Healthcare Solutions, Inc. $19.15 08/16/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
674502897 Novo Nordisk Inc $11.81 07/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
681197383 Genentech USA, Inc. $16.53 01/14/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928093 Novo Nordisk Inc $4.95 01/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928097 Novo Nordisk Inc $8.78 05/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928101 Novo Nordisk Inc $0.32 05/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928107 Novo Nordisk Inc $2.68 06/03/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928111 Novo Nordisk Inc $2.50 06/02/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928115 Novo Nordisk Inc $1.35 07/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928119 Novo Nordisk Inc $7.63 08/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928123 Novo Nordisk Inc $0.30 08/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928128 Novo Nordisk Inc $3.19 10/23/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
682928131 Novo Nordisk Inc $0.58 10/23/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
690104643 Novo Nordisk Inc $13.06 06/25/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
690104693 Novo Nordisk Inc $12.54 12/03/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
690104697 Novo Nordisk Inc $12.54 12/03/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
690104699 Novo Nordisk Inc $12.54 12/03/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
690104713 Novo Nordisk Inc $12.25 09/10/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.